Audio

Russell Rosenberg, PhD

Publish date: June 13, 2018

At SLEEP 2018, Dr. Rosenberg describes phase I trials that assessed patients' driving performance, ability to be awakened, and postural stability after taking the investigational sleep–wake regulation drug lemborexant, compared with active and placebo comparators.

 

Recommended Reading

Is Sodium Oxybate Effective in Children With Narcolepsy?
MDedge Neurology
MDedge Daily News: Lupus is quietly killing young women
MDedge Neurology
REM sleep behavior disorder predicts impending synucleinopathy
MDedge Neurology
Poor sleep tied to suicidal behaviors in college students
MDedge Neurology
Americans are getting more sleep
MDedge Neurology
Identifying insomnia in people with mental disorders
MDedge Neurology
Impact of marijuana on sleep not well understood
MDedge Neurology
Sleep apnea treatment may not prevent sleepiness
MDedge Neurology
OSA with worsening hypoxemia raises metabolic syndrome risk
MDedge Neurology
What Is the Impact of Adverse Childhood Experiences on Sleep in Adulthood?
MDedge Neurology